ftyozk.png?1733166220

Yutaka🎓CELTAbyAug,Ph.D.KyotoUniv🏅TOEIC IELTS🗣️Interpreter🌍🩺European Pharma👨‍💼MBA🧬 cancer treatment 💊

🔥All ages🧑‍🎓Conversation|Exams
393 cursos terminados

sobre você

Speaks
InglêsC2 Proficient
JaponêsNative
Chinês simplificadoA1 Beginner
🌳🌳🌳Diplomas and Qualifications🌳🌳🌳 🌳Ph.D. in Biochemistry and Cellular & Molecular Biology, Kyoto University (Apr. 1996 – May 1999) 🌳M.Sc. in Biochemistry and Cellular & Molecular Biology, Kyoto University (Apr. 1994 – Mar. 1996) 🌳B.Sc. in Biology and B.Sc. in Physics, Kyoto University (Apr. 1990 – Mar. 1994) 🌳ESL at University of California, Berkeley, CA, USA (Jun. 1991 – Aug. 1991) 🌳TOEIC 925 (Nov 2018) 🌳Chugai internal workshop training on quality of clinical documents: QMS, CAPA, eTMF, Inspection Readiness (Nov 2017) 🌳Business Leadership Training Course (MBA), Takeda Pharmaceutical Co. Ltd. (May 2006 - Mar 2007) 🌳Analytical & Quantitative Light Microscopy Course, MBL (Marine Biological Lab) in Woods Hall, MA, USA (Jul 2000) 🌳🌳🌳 Work Experience🌳🌳🌳 🌳Medical Consultant (May 2022 – Present) 🌳Senior Director of Molecular Science Liaison (MSL), Japan, Caris Life Sciences (Apr. 2022 – May 2022) 🌳Head of Oncology Medical Affairs, Merck Biopharma Co. Ltd., Japan (Nov. 2021 – Mar. 2022) 🌳Senior Manager (SM), Oncology Clinical Science, Chugai Pharmaceutical Co. Ltd. (Oct. 2020 – Oct. 2021) 🌳Senior Leader (SL), Oncology Clinical Science & Strategy Department, Chugai Pharmaceutical Co. Ltd. (Jul. 2018 – Sep. 2020) 🌳Clinical Science Leader (CSL), Oncology Clinical Science & Strategy Department, Chugai Pharmaceutical Co. Ltd. (Nov. 2017 – Jun. 2018) 🌳Oncology Medical Scientific Liaison (MSL), AbbVie GK (Sep. 2016 – Oct. 2017) 🌳Principal Scientist, Extra Value Generation & General Medicine (XVgen) Drug Discovery Unit (DDU), Takeda Pharmaceutical Co. Ltd. (Apr. 2012 – Aug. 2016) 🌳Principal Scientist, Oncology Drug Discovery Unit, Takeda Pharmaceutical Co. Ltd. (Sep. 2005 – Mar. 2012) 🌳Research Associate, Howard Hughes Medical Institute, University of Colorado Denver, CO, U.S.A. (Feb. 2000 – Jun. 2005) 🌳🌳🌳 Key Strengths 🌳Communicative, proactive, and agile 🌳Fluent in communication with lab researchers and clinical investigators in English and Japanese 🌳Logical, analytical, and persistent thinking 🌳Strong scientific background with extensive work experience in medical affairs and clinical development 🌳Capable of quickly analyzing academic and industry publications, including documents in Japanese 🌳Proactively proposes ideas and solutions to clients for fulfilling unmet needs in summary reports 🌳🌳🌳 Achievements🌳🌳🌳 🌳Published two first-author papers on "Science", the top scientific journal in the world, on the mechanism of centrosome duplication and DNA replication coordination. 🌳Initiated and implemented novel treatment strategies and biomarker studies in oncology. 🌳Developed a global network with esteemed scientists in academia and the pharmaceutical industry. 🌳17 years of experience in four global pharmaceutical companies focused on cancer research and clinical development. 🌳Invented and filed a patent for a new cancer treatment method showing synergy in anti-tumor effects (WO 2010038428A1). 🌳Delivered multiple oral presentations at international conferences such as EMBO/EMBL and APOCB. 🌳🌳🌳About Yutaka Matumoto🌳🌳🌳 🌳I was born and raised in Japan, where my early years were filled with an inherent curiosity about the natural world and an intense passion for understanding the mechanisms of life. From a young age, I displayed a keen interest in science and mathematics, which guided me toward a path of academic rigor and exploration. As I progressed through my schooling, I developed an unwavering determination to excel in my studies, often staying up late into the night to pore over textbooks and conduct small experiments in my home. 🌳My journey in higher education began at Kyoto University, where I pursued a Bachelor of Science in Biology and Physics. The dual focus allowed me to cultivate a comprehensive understanding of both the natural and physical sciences, laying the groundwork for my future research. The environment at Kyoto University was competitive, pushing me to consistently strive for excellence. My hard work paid off when I was accepted into the university’s prestigious master's program in Biochemistry and Cellular & Molecular Biology. 🌳The transition to graduate school marked a period of intense focus and discipline. I immersed myself in research, driven by the desire to contribute to the scientific community in meaningful ways. This led to my decision to pursue a Ph.D. in Biochemistry and Cellular & Molecular Biology at Kyoto University. The doctoral years were filled with challenges, including long hours in the laboratory, complex experimental procedures, and the rigorous process of scientific writing. Yet, these challenges only strengthened my resolve. I successfully defended my dissertation, which centered on the intricate processes of cellular function and replication. 🌳My postdoctoral work took me to the United States, where I joined the Howard Hughes Medical Institute at the University of Colorado Denver. There, I published groundbreaking research that unveiled the mechanisms behind centrosome duplication and its correlation with DNA replication in somatic cells. These findings, published as first-author papers in the renowned journal Science, were celebrated as pioneering contributions that provided new insights into cellular biology and the underlying causes of genomic instability associated with cancer. 🌳After my postdoctoral success, I embarked on a career spanning over 17 years in the pharmaceutical industry. I worked at four global pharmaceutical companies, including Chugai Pharmaceutical (Roche Group), AbbVie, Takeda, and Merck Biopharma. In these roles, I led innovative projects in oncology, designed biomarker studies, and contributed to early and late-stage clinical development. As a Senior Manager and later as a Director of Medical Affairs, I managed and mentored teams, developing a network with leading researchers and key opinion leaders (KOLs) worldwide. 🌳One of my most notable achievements was my leadership in developing clinical strategies for novel cancer therapies, such as the combination of immune checkpoint inhibitors and targeted treatments. My strategic insight and ability to propose original ideas led to successful collaborations and partnerships with global biotechnology firms and academic institutions. I also filed a patent for a novel treatment approach involving p38 MAPK inhibitors in combination with paclitaxel for Ras-mutated cancers, demonstrating reduced side effects and enhanced efficacy. 🌳Throughout my career, I have remained dedicated to advancing scientific knowledge and improving patient outcomes. My work has consistently reflected my commitment to excellence, from conducting high-impact research to mentoring young scientists and contributing to strategic discussions at international conferences. This dedication to science, paired with a desire to innovate and collaborate, has defined my professional journey and solidified my reputation as a leader in the fields of oncology research and medical consulting. 🌳In addition to the professional work mentioned above, I have always valued communication and connecting with people. I enjoy exploring new fields, and with the recent advancements in AI, I discovered AmazingTalker. This platform allows me more time to meet people from around the world who are interested in Japan, as well as Japanese individuals keen on the English-speaking world. I hope to contribute my skills here and make meaningful connections, building friendships along the way. 🌷🌷🌷Matumoto‘s class( English & Japanese) 🌷(4-12 years old): 🌷 Using English and Japanese materials for preschoolers and elementary students for systematic learning. Continuing with current learning materials is also possible. 🌷 Learning and familiarizing themselves with English and Japanese grammar structures and origins. 🌷 Ample opportunities for reading, expression, and games to make classes more enjoyable. 🌷 Engaging in fun story card activities to practice spoken Japanese. 🌷🌷🌷 (12-18 years old): 🌷 Using middle school textbooks for systematic learning. Continuing with current learning materials is also possible. 🌷 Teaching techniques for pronunciation and intonation to maximize learning efficiency. 🌷 Ample opportunities for reading, expression, and games to make classes more enjoyable. 🌷 Explaining vocabulary and allusions to increase vocabulary and improve speaking and writing skills. 🌷🌷🌷For adults: (Please provide specific details or requirements for adult learners so that I can provide more accurate information.) 🌷🌷🌷 Conducting lessons in Japanese, and English: 🌷 Addressing pronunciation issues and correcting them one by one. Starting from zero foundation with no pressure. 🌷 Strengthening overall English and Japanese speaking, listening, reading, and writing abilities. 🌷 Assisting in passing JLPT (N1-N5) ESL TOFEL by teaching solving techniques, planning study schedules, and providing ample practice and mock exams. 🌷 Teaching writing tips and enhancing writing skills in English and Japanese. 🌷 Explaining questions in English, Japanesevto facilitate quick understanding for students. 🌷 Mastering grammar skills to easily achieve high scores. 🌷 Assisting students in preparing for English and Japanese language interviews to secure positions in renowned Japanese companies. 🌷 Explaining unique business etiquette and response strategies in the English and Japanese workplace. 🌷 Engaging in various business dialogue scenarios to equip students with skills for handling different situations. 🌷 Learning the writing style of English and Japanese business letters, including the structure and effective phrases. 🌳🌳🌳 Matumoto Yutaka ’s Teaching Materials (Publications by Nakano Team)🌳🌳🌳 🌳🌳🌳 1. English Japanese Teaching Method & Materials for Adults: This material aims to break away from traditional textbook education, focusing on improving listening and speaking skills, enhancing the element of fun, and facilitating immediate comprehension and remarkable memorization for adult learners. 🌳🌳🌳 2. English Japanese Teaching Method & Materials for Children (Ages 3-5, 6-12, 13-18): These online courses and materials are highly favored by children. Regardless of other teachers they may encounter, children are irresistibly drawn back to Matumoto’'s engaging and captivating teaching materials. 🌳🌳🌳 3. English Japanese Teaching Games for Children (Ages 3-5, 6-12, 13-18): These online educational games have established Matumoto as an unbeatable force in Japanese language instruction, particularly for young learners. 🌳🌳🌳 4. Each lesson by Matumoto includes uploaded listening MP4 materials. These materials allow students to easily practice listening and speaking during activities such as eating, driving, or waiting for transportation. 🌳🌳🌳 Free access to the team's dedicated teaching materials, including handcrafted textbooks, literature, games, and MP4 lesson plans, contributed by Nakano and other teachers as part of their commitment to education. ➡️ Plot your learning journey with me! ➡️ A detailed analysis of your current level ➡️ A problem-solving mini-lesson ➡️ Valuable learning methods to stop wasting time! ❗️Classroom Rules ❕ ↘️ Bring your pen and a notebook to collect useful expressions in class. ↘️ Always check your connection and devices before class starts. ↘️ Cancel the class 24 hours before class. If you have to cancel a class within 24 hours, be sure you notify me through What’s App/AT Chat
ler mais
conhecer mais
mais tempo disponível
Mais descontos com 5 cursos terminados. Veja o preço no fundo ou no carrinho!

duração

ver toda a agenda
Class videos can be downloaded
Videos from one-on-one courses can be downloaded within one year after the course ends, greatly enhancing your learning experience!
( This bonus only available for students who enable the class recording function)

97 comentários sobre o curso de

ver 97 comentários

desempenho do professor

currículo

experiência

  • 2024 Até à data YUTAKA Medical Consultant
  • 2022 - 2024 YUTAKA Medical Consultant
  • 2022 - 2022 Caris Life Sciences, Japan (Caris K.K.)
  • 2021 - 2022 Merck Biopharma Co. Ltd., Merck KGaA Group, Japan
  • 2020 - 2021 Chugai Pharmaceutical Co. Ltd., Roche Group
  • 2018 - 2020 Chugai Pharmaceutical Co. Ltd., Roche Group
  • 2017 - 2018 Chugai Pharmaceutical Co. Ltd., Roche Group
  • 2016 - 2017 AbbVie GK
  • 2012 - 2016 Takeda Pharmaceutical Co. Ltd
  • 2005 - 2012 Takeda Pharmaceutical Co. Ltd
  • 2000 - 2005 Howard Hughes Medical Institute, University of Colorado Denver, CO, U.S.A.
  • 1990 - 1992 JTB (Japan Travel Bureau)
  • 1991 - 1992 Tennouji Yobikou (天王寺予備校)

educação

  • 1995 - 1999 Kyoto University Cancer Cell Biology (Molecular Cell Biology & Biochemisty) certificados carregados

  • 1995 - 1999 Kyoto University Biology (Molecular Biology and Biochemistry and Cell Biology) certificados carregados

experiência
  • 2024 Até à data YUTAKA Medical Consultant
  • 2022 - 2024 YUTAKA Medical Consultant
  • 2022 - 2022 Caris Life Sciences, Japan (Caris K.K.)
  • 2021 - 2022 Merck Biopharma Co. Ltd., Merck KGaA Group, Japan
  • 2020 - 2021 Chugai Pharmaceutical Co. Ltd., Roche Group
  • 2018 - 2020 Chugai Pharmaceutical Co. Ltd., Roche Group
  • 2017 - 2018 Chugai Pharmaceutical Co. Ltd., Roche Group
  • 2016 - 2017 AbbVie GK
  • 2012 - 2016 Takeda Pharmaceutical Co. Ltd
  • 2005 - 2012 Takeda Pharmaceutical Co. Ltd
  • 2000 - 2005 Howard Hughes Medical Institute, University of Colorado Denver, CO, U.S.A.
  • 1990 - 1992 JTB (Japan Travel Bureau)
  • 1991 - 1992 Tennouji Yobikou (天王寺予備校)
educação
  • 1995 - 1999

    Kyoto University

    Cancer Cell Biology (Molecular Cell Biology & Biochemisty) certificados carregados

  • 1995 - 1999

    Kyoto University

    Biology (Molecular Biology and Biochemistry and Cell Biology) certificados carregados

FAQ

como se reserva

  • Depois da sua compra, reserve o curso de acordo da agenda do seu professor.
  • Pode começar o curso agora com os professores que 'pode ensinar agora'
  • Pode reservar cursos dentro de 24 horas com professores offline

sobre o preço

  • A sessão de julgamento dura 25 minutos
  • Um curso oficial dura 50 minutos
  • Mais descontos com 5 cursos oficiais terminados. O desconto tem por base o preço do professor.

instrução

  • Fique no sítio 10 minutos antes do curso. Clique no 'os meus cursos', clique 'entrar a sala de aula' e começar o curso na sala de aula de ZOOM
  • Pode-se usar ZOOM em telemóveis e computadores. (baixe a app de ZOOM no seu telemóvel)

sobre o reembolso

  • Clique no 'informar um problema' quando se encontrar problemas sobre os cursos. O professor pode reprogramar ou reembolsar moedas AT.
  • O sistema reembolsa moedas AT se o professor não respondesse dentro de 12 horas.
como se reserva
  • Depois da sua compra, reserve o curso de acordo da agenda do seu professor.
  • Pode começar o curso agora com os professores que 'pode ensinar agora'
  • Pode reservar cursos dentro de 24 horas com professores offline
sobre o preço
  • A sessão de julgamento dura 25 minutos
  • Um curso oficial dura 50 minutos
  • Mais descontos com 5 cursos oficiais terminados. O desconto tem por base o preço do professor.
instrução
  • Fique no sítio 10 minutos antes do curso. Clique no 'os meus cursos', clique 'entrar a sala de aula' e começar o curso na sala de aula de ZOOM
  • Pode-se usar ZOOM em telemóveis e computadores. (baixe a app de ZOOM no seu telemóvel)
sobre o reembolso
  • Clique no 'informar um problema' quando se encontrar problemas sobre os cursos. O professor pode reprogramar ou reembolsar moedas AT.
  • O sistema reembolsa moedas AT se o professor não respondesse dentro de 12 horas.

mais professores como assim

AI recomenda professor

Deixe uma demanda e recomende um professor para você em 3 minutos!
25 mins
50 mins
falar com o professor